跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
BUTRANS 15
Authorized
STANDARD
BUTRANS 15
purdue pharma
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2ecb2c40449f5395
Company
purdue pharma
Type
Standard
Approval Details
Approval Id
2ecb2c40449f5395
Drug Approval Canada Name
BUTRANS 15
Product Name
BUTRANS 15
Status
Marketed
Status Date
2016-06-15
Original Market Date
2016-06-15
Din
02450771
Drug Class
Human
Dosage Form
Patch
Route Of Administration
Transdermal
Schedule
Narcotic (CDSA I)
Ahfs
28:08.12
Atc Original
N02AE01 BUPRENORPHINE
Atc Name
n 02 ae 01
Aig Number
0142241009
Company Name
purdue pharma
Company Address
310, 3381 Steeles Avenue East, Toronto, Ontario, Canada, M2H 3S7
Active Ingredients
BUPRENORPHINE
15 MCG / HOUR
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2ecb2c40449f5395
Type
Standard
Back to Health Canada Approvals
BUTRANS 15 - Health Canada Drug Approval Details